Last mentioned: Mar 17, 2026
Mental Health Focus
Cannabis clinics see a surge in patients seeking treatment for anxiety and PTSD.
Clinical Findings Released
The Lancet publishes data showing no significant benefit over placebo for psychiatric conditions.
Legalization Milestone
Australia legalizes medicinal cannabis at the federal level, sparking industry growth.
A comprehensive study published in The Lancet concludes that medicinal cannabis is largely ineffective for treating anxiety, depression, and PTSD. These findings challenge the rapidly growing global market for cannabinoid-based mental health treatments and highlight a significant gap between patient perception and clinical evidence.
A landmark study published in The Lancet has concluded that medicinal cannabis is no more effective than a placebo in treating anxiety, depression, and PTSD. The findings challenge the multi-billion dollar cannabis industry's reliance on mental health prescriptions and could trigger significant regulatory shifts.